Cargando…
Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
BACKGROUND: Use of gonadotropin-releasing hormone (GnRH) agonists has become popular for virtually all stages of prostate cancer. We hypothesized that some men receive these agents after only a limited work-up for their cancer. Such cases may be missed by tumor registries, leading to underestimates...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483971/ https://www.ncbi.nlm.nih.gov/pubmed/18620606 http://dx.doi.org/10.1186/1472-6963-8-146 |